Project Details
Description
C928-010: An Open- Label, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamic Signals of DUR-928 in Patients with Alcoholic Hepatitis
| Status | Finished |
|---|---|
| Effective start/end date | 10/24/18 → 3/31/19 |
Funding
- DURECT CORPORATION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.